Kimmie McLaurin - Concepedia

Author

Kimmie McLaurin

Also Known As

K K McLaurin, K McLaurin, K. K. McLaurin, K. McLaurin, K. Mclaurin, K.K. McLaurin, Kimmie K McLaurin, Kimmie K. McLaurin, Kimmie K. Mclaurin, Kimmie McLaurin

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United States)Outcomes Research Consortium Merck & Co., Inc., Rahway, NJ, USA (United States)Truven Health Analytics (United States)Children's Medical Center

About

Kimmie McLaurin is an author at AstraZeneca (United States) specializing in medicine, health services research, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	420
2	Public Health	3	3	378
3	Nursing	1	1	42
4	Allergy	1	1	299
5	Epidemiology	1	1	48

Kimmie McLaurin

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma Jasmina Ivanova, Rachel Bergman, Howard G. Birnbaum, Journal of Allergy and Clinical Immunology AsthmaSevere Persistent AsthmaPulmonary CareAllergyHealth Economics	2012	299
Persistence of Morbidity and Cost Differences Between Late-Preterm and Term Infants During the First Year of Life Kimmie McLaurin, Caroline Breese Hall, Elizabeth A. Jackson, PEDIATRICS	2009	230
A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma Chad K. Oh, Richard Leigh, Kimmie McLaurin, Respiratory Research	2013	138
Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants Kimmie McLaurin, A. Farr, Sally W. Wade, Journal of Perinatology	2016	132
Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997–2012 Abigail Doucette, Xiaohui Jiang, Jon P. Fryzek, PLoS ONE	2016	83
SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis Evan J. Anderson, John P. DeVincenzo, Eric A. F. Simões, American Journal of Perinatology	2019	80
SENTINEL1: An Observational Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis Evan J. Anderson, Leonard R. Krilov, John P. DeVincenzo, American Journal of Perinatology	2016	67
A Real-World Evidence Study of CDK4/6 Inhibitor Treatment Patterns and Outcomes in Metastatic Breast Cancer by Germline BRCA Mutation Status Jenna Collins, Beth Nordstrom, Kimmie McLaurin, Oncology and Therapy	2021	55
The 2014–2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States Amanda M. Kong, Leonard R. Krilov, Jaime Fergie, American Journal of Perinatology	2017	52
Healthcare costs within a year of respiratory syncytial virus among medicaid infants Liisa Palmer, Caroline Breese Hall, Julie P. Katkin, Pediatric Pulmonology Outpatient RsvPediatric Lung DiseasePediatric EpidemiologyMedicaid InfantsClinical Epidemiology	2010	48

Page 1